Peroxisome proliferator-activated receptor gamma agonists can upregulate PGC-1α, NRF1, TFAM, and cytochrome c oxidase subunits I and IV and enhance mitochondrial biogenesis in ischemic stroke (Yang et al., 2018). The gene discussed is NRF1; the disease is ischemic stroke.